of the zebrafish genetic map and ongoing genome projThe University of Texas Southwestern ect have led to an ability to clone the corresponding Medical School genes within a relatively short time span (3-6 months).
Zebrafish Genetics: An Experimental System Vascular Lineages and Therapeutic Angiogenesis Linking Cardiovascular Development
In 1994, the first report of therapeutic angiogenesis and Disease based on the single administration of one angiogenic Zebrafish genetics is beginning to uncover genes and factor, VEGF, appeared (Takeshita et al., 1994) . This pathways for cardiac development at a breathtaking result pointed to the promise of therapeutic angiogenesis as a new molecular therapy for chronic coronary and peripheral arterial disease. Although therapeutic an- ). Accordingly, it may be over-simplistic to expect that the complexity of vasculogenesis. One of the obligatory triggers for angiogenesis is VEGF, a factor that has been administration of a single gene would be sufficient to promote therapeutic coronary or peripheral arteriogeneshown to be both necessary and sufficient for angiogenesis in vivo. However, recent studies of a host of addisis, without first identifying the unique combination of core and tissue-specific angiogenic programs required tional angiogenic factors, including angiopoietins-1 and -2 (Yancopoulos et al., 2000) (Regeneron), suggest that in the target organ of interest. This may be particularly important for therapeutic coronary arteriogenesis, as additional components may be required to form fully mature vessels that contain pericytes, smooth muscle the formation of the coronary arterial system in the fetal heart is now known to require concerted developmental cells, and distinct endothelial subtypes. Further, VEGF can specifically induce expression of the synergistic cues derived from four discrete lineages: endothelial, myocardial, pro-epicardial, and neural crest lineages factor angiopoietin-2 in muscle cells by an intracellular pathway, but not when administered exogenously. This (Figure 1 ably, in addition to these hypertensive genes, another patients with TBX1 mutations have been found that disset of human mutations has been found that lowers play the full spectrum of cardiac neural crest defects, blood pressure. All of these genes have their primary suggesting that other genes in this minimal region may effect in renal cell lineages, pointing to the central role contribute to the human phenotype. In this regard, of the kidney in the onset of human hypertension. As TBX1-deficient mice only display a subset of the neural noted by Rick Lifton (Yale), while it is clear that blood crest defects found in DiGeorge children (aortic arch pressure can be controlled by a number of different anomalies), again providing support for DiGeorge as a agents that work outside of these renal pathways, the contiguous gene syndrome. Given the number of genes question arises as to whether the design of specific in the minimal critical region of chromosome 22, and antagonists to these specific renal targets might have the existence of non-overlapping deletions that result long-term beneficial effects that go beyond effects on in the same phenotype, it is likely that positional effects the control of blood pressure per se, but extend to and long-range chromatin interactions contribute to the chronic effects of hypertension on end-organ diseases difficulty in pin-pointing a single gene as the culprit in all aspects of this disease.
of the heart, brain, or the kidney itself. The recent unsus-pected major therapeutic benefit of mineralocorticoid of myocardin can prevent heart formation in frog embryos. It will be of interest to identify additional cofactors antagonists in heart failure raises interesting questions about the potential role of this nuclear hormone receptor for myocardin and to investigate its potential roles in cardiac gene expression during later stages of developin heart muscle cells. Accordingly, it will be interesting to cross mice that harbor cardiac-restricted mutations ment and disease. In addition, the growing database of putative cardiac transcriptional regulators suggests new of this gene into well-characterized mouse models of cardiomyopathy and heart failure. In short, the discovery insights in the combinatorial pathways that control the gene program may be on the horizon (J. Epstein, Univerof these new pathways responsible for rare forms of human hypertension is beginning to provide novel insity of Pennsylvania, and E. Olson, UTSW). A zebrafish mutant, liebeskummer, with an excess of sights and therapeutic targets for common forms of the disease. The identification of a number of quantitative cardiomyocytes was also reported (M. Fishman, MGH). The mutation was shown to activate reptin, an ATPtrait loci (QTLs) in spontaneous in-bred hypertensive rat strains (Jacob and Kwitek, 2002), coupled with the dependent helicase that acts through an as yet unknown mechanism to control growth of the ventricles. Ventricuongoing advances in the rat genome project, suggest that additional insight into genetic pathways for the conlar growth in the embryo is dependent on signals from the overlying epicardium. Andrew Lassar (Harvard) pretrol of hypertension will be forthcoming from experimental model systems, which should allow a direct comparisented evidence that epicardial signaling requires Epo and retinoic acid, which act through parallel pathways son in studies of more common forms of hypertension in human populations. The adult myocardium responds to extrinsic forms of stress such as hypertension, myocardial infarction, and the damaged adult myocardium. However, it appears that forming a cardiac muscle cell is not so simple. While pressure-overload by a hypertrophic growth response (for a review, see Chien, 1999) . Inherited mutations in several cardiac-restricted transcription factors have been identified, none have been found to possess the components of the sarcomere and cytoskeleton also result in hypertrophic cardiomyopathy. Hypertrophy in ability to confer cardiac identity on their own. However, combinations of factors such as the zinc finger protein response to pathologic stimuli is accompanied by activation of a fetal gene program, which results in maladap-GATA4, the homodomain proteins Nkx2.5 and Tbx5 and the MADS box protein serum response factor (SRF) are tive changes in contractility and calcium handling (Figure 2) . Growth of the heart during normal postnatal able to activate some cardiac genes in transfected cells. Tim Mohun (NIMR, UK) reported that ectopic expression development and in response to exercise also occurs through hypertrophy. A key issue in the field is to deciof GATA4 in injected frog animal caps was capable of inducing the formation of beating cardiomyocytes. Simipher the pathways that control pathologic and physiologic hypertrophy, such that the former might be inhiblar findings have been made with GATA5 in zebrafish (D. Stainier, UCSF) (Reiter et al., 1999) . Since these GATA ited and the latter augmented pharmacologically. Changes in intracellular calcium handling have been imfactors are not restricted to the heart, and alone cannot activate endogenous cardiac genes in transfection plicated as a trigger for cardiac hypertrophy, and numerous calcium-dependent and calcium-independent (Gq, assays, they must act in conjunction with other transcription factors and signaling systems in the context RAS, PI3K, p38) (for review, see found that physiologic signals do not stimuhypertrophic signaling pathways interconnected, and how do they intersect with the calcium cycling malate MEF2 activity in the heart. Intriguingly, cardiac MEF2 activity is dramatically induced in male, but not female, chinery?
Mice engineered to express a mutant form of ␣-MHC mice that misexpress mutant MHC. Paradoxically, removal of estrogens from the diet restores cardiac funcwith a codon 403 mutation that mimics a common human mutation develop hypertrophic cardiomyopathy tion in these male mice. These findings suggest that MEF2 is a specific endpoint for pathologic stimuli that and exhibit abnormal calcium homeostasis, such that the mutant sarcomere requires a greater amount of callead to hypertrophy, and that there is a gender-specific influence on this stress-response pathway. Thus, apcium than the wild-type sarcomere to generate the same level of force (Fatkin et al., 2000) . SR calcium levels proaches that specifically interfere with upstream signaling pathways that lead to MEF2 activation might have are also reduced in these mutants, suggesting that the mutant sarcomere sequesters a higher level of calcium clinical benefit as anti-hypertrophic agents. than wild-type, with resulting perturbation in intracellular calcium homeostasis. This notion is supported by the
Mechanical Signaling
In addition to these recent advances in dissecting the finding that the L-type calcium channel blocker diltiazem restores SR calcium levels and normal contractility and signaling cascades and transcriptional mediators of hypertrophy, genomic databases are also uncovering a prevents hypertrophy in the mutant heart. Jon Seidman (Harvard) presented evidence suggesting that sarcogrowing number of novel cytoskeletal genes whose products play pivotal roles in mechanosignaling and mere mutations may activate different hypertrophic signaling pathways from pressure overload. However, the stress-responsiveness (for a review see Chien, 2000;
Clarke et al., 2002
). An expanding number of these novel, molecular mechanisms whereby sarcomere mutations result in hypertrophic cardiomyopathy remain unknown. muscle-specific cytoskeletal components are localized in the cardiac Z disc, thereby implying that the Z disc Another major question in the field is to determine how hypertrophic signals are transmitted to the nucleus, may play a specialized function beyond a purely structural role (Figure 3) . At the Z disc, ␣-actinins are orgawith resulting reprogramming of cardiac gene expression. The MEF2 transcription factor appears to be a nized into a series of anti-parallel dimers, which crosslink polymerized actin filaments (thin filaments). The Z critical target for hypertrophic signals, as revealed with The interzonal myocardial rings from the linear heart tube to the four chambered heart correspond, in part, to components of the specialized cardiac conduction system including the SAN, AVN, and Bundle of His and PF (rings and components of the conduction system are color coded). Looping of the immature heart tube brings these rings to their approximate positions in the mature heart. Normal electrophysiological function of the heart depends on proper development of all lineages within the cardiac conduction system, as illustrated by the distinct electrophysiological profile of each individual component. Disruption of any one of these components is not lethal, but can lead to numerous electrophysiological defects. A number of genes have been identified in various components of the conduction system including, but not exclusive to, connexin-40, HF1b, nkx2.5, and tbx5. Mouse knockout models for each of these genes have been studied revealing numerous electrophysiological defects related to abnormalities in various components of the conduction system. VKO: ventricular restricted knock out; SAN sinus node; A, atria; AVN, atrioventricular node; PF, Purkinje fiber; V, ventricle; B, common bundle; BB, bundle branches; CHD, congenital heart defects; CM, cardiomyopathy; AVB, AV block; SP, sinus pause; VT, ventricular tachycardia.
Conduction Lineages and Arrhythmogenesis
and genomic databases could eventually be instructive in identifying these molecular pathways. The orderly propagation of cardiac electrical impulses is mediated by a spatially restricted network of specialized Defects in the developmental pathways that control conduction system formation have now been directly conduction system cell lineages (Figure 4 ., 2001 ). This mouse has allowed a detailed view of the maturing conductive system network diac sudden death and marked tachy and brady arrhythmias. Since HF1b is expressed in ventricular myocarand together with optical mapping studies correlating morphology of the conduction system with functionality, dium as well as the neural tube, which gives rise to the neural crest, the question arises as to where the these studies provide a basis for understanding the regulatory circuitry guiding conduction system specializarequirement for HF1b is located with respect to the defects in conduction system lineages. Neural crest lintion (see Figure 4 ). Utilizing this model, a direct role for neuregulin pathways in triggering the formation of the eages are important for the formation of the autonomic nervous system that innervates the AV node, and also conduction system has been found (Rentschler et al., 2002) , which may represent one of the subendocardial are critical for the formation of the coronary arterial system, which has been shown to generate cues for Purcues that has been suspected to contribute to this transition. Since each of the components of the conduction kinje fiber formation. As a number of neural-restricted genes are expressed within conduction system linsystem has distinct electrophysiological properties (SA node, AV node, His bundle, Purkinje; see Figure 4 ), there eages, it will become of interest to define more precisely the contribution of neural crest lineages to conduction must be additional factors that lead to the formation of specific conduction system lineages. New models that system development (K.R.C., UCSD). Recent studies of patients with familial forms of conwill allow the sorting of conduction system cell lineages, genital heart disease also support the concept that detion, studies by two independent groups also support a negligible level of transduction of host cells to cardiac fects in transcriptional factors can lead to cardiac arrhythmogenesis via effects on both ventricular and myocytes in transplanted human hearts (C. Murry, J. Epstein) (Glaser et al., 2002). While the hope remains conduction system lineages. Patients that harbor mutations in the transcription factor TBX-5 display large atrial that cardiac homing of circulating hematopoietic stem cells might participate in repair of the injured myocarseptal defects and a wide spectrum of other cardiac malformations that can be associated with severe condium, it is also apparent that the endogenous repair process is inadequate to improve cardiac function folduction defects (Bruneau et al., 2001) . The question has arisen as to whether the conduction system defects are lowing damage. Thus, future efforts should be directed toward the identification of signals involved in attraction, simply secondary to the structural defects in the heart and associated distortion of conduction system develproliferation, and cardiogenic conversion of circulating stem cells. opment. Recent studies in TBX-5-deficient mice support the concept that TBX-5 may have dual effects on the One of the fundamental differences between cardiac and skeletal muscle is that skeletal muscle is able to disruption of the normal spatial configuration of the developing conduction system, as well as cell-autonoregenerate in response to damage by the awakening of quiescent precursor cells, known as satellite cells, which mous effects on conduction lineages, as TBX5 appears to be a direct transcriptional regulator of the Connexinlie between the basal lamina and the muscle fiber. ., 1995) . It will become of interest to determine if this association with NKX2.5 and IGF-1 might serve as a priming stimulus to recruit and commit circulating stem cells to the myogenic lineage in cardiac arrhythmias represents a direct effect on conduction system cell lineages, thereby reflecting an addidamaged or degenerating muscle (N. Rosenthal, EMBL), suggesting that there might be a similar effect for cardiac tional role for this homeobox gene at later stages of cardiac maturation, including the postnatal myocardium lineages as well. Establishing high throughput assay systems that eventually will allow the expression cloning (K.R.C., UCSD). The list of genetic pathways for cardiac arrythmogenesis that arise from developmental defects and/or biochemical identification of the external factors and cues required for cardiac stem cell renewal and in conduction system lineages is likely to grow as the pathways that control conduction system development recruitment should now be possible. Microarray and bioinformatics approaches to identify possible cytocontinue to be unraveled by multiple laboratories. kines and other extracellular factors involved in stem cell attraction and propagation in the heart also represent Stem Cell Lineages and CV Disease potentially powerful approaches to this problem. CurThe major causes of heart failure are related to the onset rently, the realistic prospects for stem cell therapy for of cardiac injury by a variety of pathological stimuli, cardiac repair appear to be distant, based on the need particularly after the irreversible damage that arises from to purify and to deliver in vivo a sufficient quantity of myocardial infarction. The longstanding axiom has been the cells to improve global cardiac function, and the that the myocardium has a limited capacity for self repair potential for electrophysiological heterogeneity that or regeneration, and the irreversible loss of muscle sets could represent the substrate for arrhythmogenesis. A into play a series of events that ultimately leads to inlonger term, but perhaps more feasible strategy would creased wall stress, chamber dilation, and progressive be to identify the factors required for self renewal and heart failure. The loss of myocyte survival cues is associrecruitment of cardiac stem cells into the injured myoated with diverse pathways for heart failure (Chien, cardium. 1999), underscoring the importance of maintaining the number of viable heart muscle cells during heart failure progression. This axiom has recently been challenged 
